研究業績

2014

Papers (English)


 
Original papers


1. Akagi A, Ono K, Hamaguchi T, Samuraki M, Nakada M, Shima Y, Oohata T, Yamada M. Neurolymphomatosis exhibiting repeated exacerbation and remission in both the peripheral and central nervous systems. J Neurol Sci 345:267-268, 2014

2. Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K,
Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A,
Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WE, Serrano-Pozo A, Shelanski ML,
Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White 3rd CL, Wisniewski T,
Woltjer RL, Yamada M, Nelson PT.. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755-766, 2014

3. Eisele YS*, Fritschi SK*, Hamaguchi T*, Obermüller U, Füger P, Skodras A, chäfer C, Odenthal J, Heikenwalder M, Staufenbiel M, Jucker M. Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis. J Neurosci 34:10264-10273, 2014 * These authors contributed equally

4. Hayashi K, Iwasa K, Morinaga A, Ono K, Yamada M. Exacerbation of myasthenia gravis by intravenous peramivir. Muscle Nerve (In Press)

5. Ishida C, Kobayashi K, Kitamura T, Ujike H, Iwasa K, Yamada M. Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques. Neuropathology (In press)

6. Iwasa K*, Shima K*, Komai K, Nishida Y, Yokota T, Yamada M. Retinitis pigmentosa and macular degeneration in a patient with ataxia with isolated vitamin E deficiency with a novel c.717 del C mutation in the TTPA gene. J Neurol Sci 345:228-230, 2014 * These authors contributed equally

7. Iwasa K, Nambu Y, Motozaki Y, Furukawa Y, Yoshikawa H, Yamada M. Increased skeletal muscle expression of the endoplasmic reticulum chaperone GRP78 in patients with myasthenia gravis.
J Neuroimmunol 273:72-76, 2014

8. Iwasa K, Yoshikawa H, Samuraki M, Shinohara M, Hamaguchi T, Ono K, Nakamura H, Yamada M. Myasthenia gravis: predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan. J Neuroimmunol 267:97-101, 2014

9. Kobayashi A, Parch P, Yamada M, Brown P, Saveroni D, Matsuura Y, Takeuchi A, Mohri S, Kitamoto T. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology? J Virol (In Press)

10. Komatsu J, Sakai K, Hamaguchi T, Sugiyama Y, Iwasa K, Yamada M. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene. Prion 8:336-338, 2014

11. Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 3:19-32, 2014

12. Miyashita A, Wen Y, Kitamura N, Matsubara E, Kawarabayashi T, Shoji M, Tomita N,
Furukawa K, Arai H, Asada T, Harigaya Y, Ikeda M, Amari M, Hanyu H, Higuchi S, Nishizawa M,
Suga M, Kawase Y, Akatsu H, Imagawa M, Hamaguchi T, Yamada M, Morihara T, Takeda M, Takao T, Nakata K, Sasaki K, Watanabe K, Nakashima K, Urakami K, Ooya T, Takahashi M, Yuzuriha T, Serikawa K, Yoshimoto S, Nakagawa R, Saito Y, Hatsuta H, Murayama S, Kakita A, Takahashi H, Yamaguchi H, Akazawa K, Kanazawa I, Ihara Y, Ikeuchi T, Kuwano R. Lack of genetic association between TREM2 and late-onset Alzheimer’s disease in Japanese population. J Alzheimers Dis 41:1031-1038, 2014

13. Monteith T, Gardener H, Rundek T, Dong C, Yoshita M, Elkind MS, DeCarli C, Sacco RL,
Wright CB. Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke 45:1830-1832, 2014

14. Murono S, Hamaguchi T, Yoshida H, Nakanishi Y, Tsuji A, Endo K, Kondo S, Wakisaka N,
Yamada M, Yoshizaki T. Evaluation of dysphagia at the initial diagnosis of amyotrophic lateral sclerosis. Auris Nasus Larynx (In press)

15. Nakamura K, Sakai K, Samuraki M, Nozaki I, Notoya M, Yamada M. Agraphia of Kanji (Chinese characters): an early symptom of sporadic Creutzfeldt-Jakob disease in a Japanese patient: a case report. J Med Case Rep 8:269, 2014

16. Nakamura K, Hamaguchi T, Yamada M. Demyelinating polyneuropathy after long-term treatment with infliximab. Int J Rheum Dis (In Press)

17. Nakamura K, Mori F, Tanji K, Miki Y, Yamada M, Kakita A, Takahashi H, Utsumi J, Sasaki H, Wakabayashi K. Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies. Neuropathology
(In Press)

18. Nakamura Y, Ae R, Takumi I, Sanjo N, Kitamoto T, Yamada M, Mizusawa H. Descriptive epidemiology of prion disease in Japan: 1999-2012. J Epidemiol (In Press)

19. Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, Iwasa K, Yokogawa M, Asai K, Komai K, Nakamura H, Yamada M. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS One 9:e96013, 2014

20. Noto D, Sakuma H, Takahashi K, Saika R, Saga R, Yamada M, Yamamura T, Miyake S. Development of a culture system to induce microglia-like cells from haematopoietic cells. Neuropathol Appl Neurobiol 40:697-713, 2014

21. Nozaki I, Kato-Motozaki Y, Ikeda T, Takahashi K, Tagami A, Ishida C, Komai K. Clinical features in association with neurodegenerative diseases and malignancies. Eur Neurol 71:99-105, 2014

22. Nozaki I, Furukawa Y, Kato-Motozaki Y, Ikeda T, Takahashi K, Tagami A, Ishida C, Komai K. Neuroleptic malignant syndrome induced by combination therapy with tetrabenazine and tiapride in a Japanese patient with Huntington’s disease at terminal stage of recurrent breast cancer. Intern Med 53:1201-1204, 2014

23. Ono K, Takahashi R, Ikeda T, Mizuguchi M, Hamaguchi T, Yamada M. Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation. Biochim Biophys Acta 1842:646-653, 2014

24. Qina T, Sanjo N, Hizume M, Higuma M, Tomita M, Atarashi R, Satoh K, Nozaki I, Hamaguchi T, Nakamura Y, Kobayashi A, Kitamoto T, Murayama S, Murai H, Yamada M, Mizusawa H. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene.
BMJ Open 4:e004968, 2014

25. Russo C, Jin Z, Homma S, Elkind MS, Rundek T, Yoshita M, Decarli C, Wright CB, Sacco RL,
Di Tullio MR. Response to letter regarding article, "subclinical left ventricular dysfunction and silent cerebrovascular disease: the cardiovascular abnormalities and brain lesions (CABL) study". Circulation 129:e486-487, 2014

26. Sakai K, Boche D, Carare R, Johnston D, Holmes C, Love S, Nicoll JAR. Aβ immunotherapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy. Acta Neuropathol 128:777-789, 2014

27. Sakai K, Hamaguchi T. Wallenberg’s lateral medullary syndrome with facial palsy caused by anterior inferior cerebellar artery territory infarct. Neuro Clin Neurosci 2:122-123, 2014

28. Takahashi K, Tagami A, Yachi H. Delayed pneumonia caused by nonionic soluble contrast media. IJCMI 1:1000179, 2014

29. Takahashi R, Ono K, Shibata S, Nakamura K, Komatsu J, Ikeda Y, Ikeda T, Samuraki M, Sakai K, Iwasa K, Kayano D, Yamada M. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. J Neurol Sci 345:231-235, 2014

30. Takamura Y*, Ono K*, Matsumoto J, Yamada M, Nishijo H. Effects of the neurotrophic agent T-817MA on oligomeric amyloid β-induced deficits in long-term potentiation in the hippocampal CA1 subfield. Neurobiol Aging 35:532-536, 2014 * These authors contributed equally

31. Wang J, Land D, Ono K, Galvez J, Zhao W, Vempati P, Steele JW, Cheng A, Yamada M, Levine S, Mazzola P, Pasinetti GM. Molecular topology as novel strategy for discovery of drugs with Aβ lowering and anti-aggregation dual activities for Alzheimer's disease. PLoS One 9:e92750, 2014

32. Wang J, Varghese M, Ono K, Yamada M, Levine S, Tzavaras N, Gong B, Hurst WJ, Blitzer RD, Pasinetti GM. Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease. J Alzheimers Dis 41:643-650, 2014

33. Willey JZ, Gardener H, Moon YP, Yoshita M, DeCarli C, Cheung YK, Sacco RL, Elkind MS,
Wright CB. Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study. Cerebrovasc Dis 37:423-430, 2014

34. Yamaguchi H, Sakai K, Yamada M. Tracking rheumatoid leptomeningitis on diffusion-weighted MRI. Intern Med (In press)

35. Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamasaki J, Yamashina S, Yamada M. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: A multicenter study. PLoS One (In Press)
 
Reviews


1. Takahashi K. Systemic lupus erythematosus with neuromyelitis optica. J Clin Cell Immunol 5:208, 2014

2. Takamori M. Structural and pathogenic mechanisms centered on muscle-specific tyrosine kinase in autoimmune neuromuscular junction disorders. Curr Immunol Rev 9:207-213, 2013 (Published in March 15, 2014)

3. Yamada M. The spectrum of cerebral amyloid angiopathy-related disorders. Intern Med 53:1893-1894, 2014

4. Varghese M, Ho L, Wang J, Zhao W, Levine S, Ono K, Mannino S, Pasinetti GM. Green coffee as a novel agent for Alzheimer’s disease prevention by attenuating diabetes. Translational Neuroscience 5:111-116, 2014
 
Book


1. Yoshita M. Value of MIBG in the differential diagnosis of neurodegenerative disorders. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Leenders KL eds. PET and SPECT in Neurology. Springer, Heidelberg New York Dordrecht London, pp437-450, 2014
 
Invited lectures


1. Yamada M. Cerebral amyloid angiopathy: emerging concept. International Conference Stroke Update 2014, Jeju, November 6-8, 2014

2. Yoshita M, Yamada M. Myocaridial sympathetic nerve imaging. 14th ICGP&19th JSNP Joint Congress, Tsukuba, October 1-4, 2014
 
Presentations


1. Ae R, Kojo T, Ysuboi S, Aoyama Y, Kotani K, Takamura H, Enkh-Oyun T, Yamada M, Mizusawa H. Epidemiologic features of human prion disease in Japan: a prospective 14-year surveillance. The 20th IEA World Congress of Epidemilogy, Anchorage, August 17-21, 2014

2. Adachi Y, Yoshikawa H. Crisis management for torpid university students through using an information aggregation system. ACHA 2014 Annual Meeting, San Antonio, May 27-31, 2014

3. Furukawa F, Sanjo N, Kobayashi A, Kitamoto T, Shiraishi A, Ishikawa K, Honda H, Yamada M, Mizusawa H. Clinical features of Gerstmann-Sträussler-Scheinker syndrome with a P105L mutation and a valine-encoding polymorphic codon 129 in the prion protein gene. PRION 2014, Trieste, May 27-30, 2014

4. Furukawa F, Sanjo N, Kobayashi A, Shiraishi A, Ishikawa K, Yamada M, Kitamoto T, Eishi Y, Mizusawa H. Involment of the dorsal root ganglion in GSS with P105L mutation. Asian Pacific Prion Symposium 2014, Jeju, July 6-7, 2014

5. Hamaguchi T, Sakai K, Nozaki I, Noguchi-Shinohara M, Sanjo N, Nakamura Y, Kitamoto T, Murayama S, Satoh K, Harada M, Mizusawa H, Yamada M. Clinical features of MM2 type sporadic Creutzfeldt-Jakob disease. Asian Pacific Prion Symposium 2014, Jeju, July 6-7, 2014 (Best Poster Award)

6. Hizume M, Sanjo N, Satoh K, Hamaguchi T, Yamada M, Iwasaki Y, Kobayashi A, Kitamoto T, Mizusawa H. Immunohistochemical and neuropathological analyses of the prion protein in genetic Creutzfeldt-Jakob disease with V180I mutation. PRION 2014, Trieste, May 27-30, 2014

7. Iwasa K, Nambu Y, Motozaki Y, Furukawa Y, Yoshikawa H, Yamada M. Increased skeletal muscle expression of the endoplasmic reticulum chaperone GRP78 in patients with myasthenia gravis. 13th International Congress on Neuromuscular Disease, Nice, July 5-10, 2014

8. Komai K, Nozaki I, Ishida C, Takahashi K, Tagami A, Kato-Motozaki Y, Ikeda T. Hypercapnic respiratory failure is often seen in advanced progressive supranuclear palsy. 66th American Academy of Neurology Annual Meeting, Philadelphia, April 26-May 3, 2014

9. Komai K, Tagami A, Ishida C, Takahashi K, Motozaki Y, Nozaki I, Ikeda T. Multidisciplinary respiratory care support team can reduce respiratory complications of neuromuscular disease inpatient. 13th International Congress on Neuromuscular Diseases, Nice, July 5-10, 2014

10. Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, Iwasa K, Yokogawa M, Asai K, Komai K, Nakamura H, Yamada M. Differences in the prevalence of dementia and mild cognitive impairment between early and delayed responders in a community-based study. Alzheimer’s Association International Conference 2014, Copenhagen, July 12-17, 2014

11. Ono K, Takahashi R, Ikeda T, Yamada M. Cross-seeding effects of amyloid β-protein and α-synuclein. Alzheimer’s Association International Conference on Alzheimer’s Disease 2014, Copenhagen, July 12-17, 2014

12. Sakai K, Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Takumi I, Sanjo N, Nakamura Y, Kitamoto T, Saito N, Mizusawa H, Yamada M. Graft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional study. Asian Pacific Prion Symposium 2014, Jeju, July 6-7, 2014

13. Sakai K, Boche D, Carare R, Johnston D, Holmes C, Love S, Nicoll J. β immunothreapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy. 18th International Congress of Neuropathology, Rio de Janeiro, September 14-18, 2014

14. Samuraki M, Matsunari I, Yoshita M, Shima K, Noguchi-Shinohara M, Hamaguchi T, Ono K, Yamada M. Regional glucose metabolism and gray-matter volume in Alzheimer’s disease with cerebral amyloid angiopathy-related microbleeds. 4th International CAA (Cerebral Amyloid Angiopathy) Conference. London, September 18-20, 2014

15. Sanjo N, Higuma M, Hizume M, Furukawa F, Nakamura Y, Kitamoto T, Yamada M, Sakai K, Nozaki I, Noguchi-Shinohara M, Hamaguchi T, Moriwaka F, Aoki M, Tanaka F, Nishizawa M,
Takeda M, Inuzuka T, Abe K, Murai H, Murayama S, Takao M, Satoh K, Harada M, Saito N, Takumi I, Mizusawa H. Human prion diseases in Japan: a prospective surveillance from 1999. PRION 2014, Trieste, May 27-30, 2014

16. Sanjo N, Higuma M, Hizume M, Furukawa F, Nakamura Y, Kitamoto T, Yamada M, Sakai K, Nozaki I, Noguchi-Shinohara M, Hamaguchi T, Moriwaka F, Aoki M, Tanaka F, Nishizawa M,
Takeda M, Inuzuka T, Abe K, Murai H, Murayama S, Takao M, Satoh K, Harada M, Saito N, Takumi I, Mizusawa H. Human prion diseases in Japan: a prospective surveillance from 1999. Asian Pacific Prion Symposium 2014, Jeju, July 6-7, 2014

17. Takahashi K, Komai K, Ishida C, Nozaki I, Ikeda T, Motozaki Y. Antiphospholipid antibodyes in patients with multiple sclerosis or neuromyelitis optica. 12th International Congress of euroimmunology, Mainz, November 9-13, 2014

18. Yoshita M, Tsuji S, Yokoyama K, Sakamoto H. The utility of amyloid imaging with PET in Alzheimer disease diagnosis. 14st Asian & Oceanian Congress of Neurology, Macau, March 2-5, 2014

19. Yoshita M, Yamada M. Myocardial sympathetic nerve imaging. 14th The International College of Geriatric Psychoneurophalmacology. Tsukuba, October 2-4, 2014
 
TOPへ戻る